Lv1
90 积分 2026-03-24 加入
Structure-based classification for differential tyrosine kinase inhibitors efficacy of EGFR exon 19 deletions in non-small cell lung cancer
10天前
已关闭
Development, validation and clinical application of a LC-MS/MS method for simultaneous determination of third-generation EGFR-TKIs and metabolites in patients with NSCLC
1个月前
已关闭
Critical Appraisal of PD-L1 Expression as a Predictive Biomarker for EGFR-TKI Efficacy in Lung Squamous Cell Carcinoma
1个月前
已关闭
Making Progress Along the Challenging Road of Drug Development for Patients With EGFR Exon 20 Insertion–Positive Non–Small Cell Lung Cancer
1个月前
已完结
皖公网安备34019202002308
